.
Thanks WST ...
I have registered.
I do have a couple of questions though which weren't directly addressed ....
There is another company listed here in Australia ... Polynovo... which states on its website
"NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair"
.
My question relates to both these companies in the open marketplace .... do Doctors choose one or the other based on them being complementary ... for example Polynovo being used to rebuild deep thick flesh with Avita's spray on skin for the surface (skin) on top of the (new) thickness of flesh built by Polnovo's product?
Another question ..... some other products in the marketplace used animal-derived products ..... both Avita and Polynovo don't have these ... will this aspect skirt problems which might arise from religious views?
.Thanks again
KB
- Forums
- ASX - By Stock
- AVH
- New Avita Medical Seeking Alpha Analysis by WST
New Avita Medical Seeking Alpha Analysis by WST, page-17
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.68 |
Change
0.150(4.25%) |
Mkt cap ! $257.1M |
Open | High | Low | Value | Volume |
$3.69 | $3.77 | $3.61 | $917.4K | 248.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 587 | $3.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.68 | 1999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 587 | 3.660 |
1 | 500 | 3.620 |
2 | 2138 | 3.600 |
1 | 278 | 3.590 |
2 | 10774 | 3.550 |
Price($) | Vol. | No. |
---|---|---|
3.680 | 1999 | 1 |
3.690 | 1273 | 2 |
3.700 | 24243 | 1 |
3.710 | 8475 | 2 |
3.720 | 351 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online